Emergent BioSolutions (EBS) Invested Capital (2010 - 2026)
Emergent BioSolutions (EBS) posted Invested Capital of $931.1 million for Q2 2026, down 16.33% on a QoQ basis from $1.1 billion in Q1 2026, and down 24.68% year-over-year from $1.2 billion in Q2 2025.
Emergent BioSolutions (EBS) Invested Capital (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Invested Capital for 17 years, with the latest figure at $931.1 million in Q2 2026.
- On a quarterly basis, Invested Capital fell 24.68% year-over-year to $931.1 million in Q2 2026; TTM through Jun 2026 was $931.1 million, a 24.68% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 5.96% from the prior year.
- Invested Capital was $931.1 million for Q2 2026 at Emergent BioSolutions, down from $1.1 billion in the prior quarter.
- The five-year high for Invested Capital was $3.8 billion in Q4 2022, with the low at $931.1 million in Q2 2026.
- Average Invested Capital over 5 years is $1.9 billion, with a median of $1.8 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Invested Capital surged 50.79% in 2022, then plunged 48.62% in 2023.
- Over 5 years, Invested Capital stood at $3.8 billion in 2022, then slumped by 48.62% to $1.9 billion in 2023, then sank by 38.76% to $1.2 billion in 2024, then fell by 5.96% to $1.1 billion in 2025, then dropped by 16.29% to $931.1 million in 2026.
- The last three Invested Capital figures came in at $931.1 million (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 145.70 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 159.97 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 51.53 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 148.69 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 66.21 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 106.05 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 6.25 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 931.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 931.10 Mn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 2.03 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 3.56 Bn |
| Dec 31, 2022 | 3.76 Bn |
| Sep 30, 2022 | 2.49 Bn |
| Jun 30, 2022 | 2.37 Bn |
| Mar 31, 2022 | 2.44 Bn |
| Dec 31, 2021 | 2.49 Bn |
| Sep 30, 2021 | 2.41 Bn |
Emergent BioSolutions Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();